Type 2 diabetes is one of the most common long-term health conditions in the world. It affects millions of people and requires ongoing care to keep blood sugar levels under control.
The first medicine most patients receive is metformin, which is widely used and generally considered safe and effective. However, many people need a second medication when metformin alone is not enough.
A new study from Northwestern University has raised concerns about some of the most commonly used second-step treatments. The research suggests that two older types of diabetes drugs may increase the risk of serious heart problems.
The study was led by Dr. Matthew O’Brien and published in the journal JAMA Network Open. It focused on two traditional treatment options: sulfonylureas and basal insulin. These drugs have been used for many years and are still widely prescribed today.
Sulfonylureas help the body produce more insulin, while basal insulin provides a steady level of insulin throughout the day. Both can lower blood sugar effectively. However, the new research suggests that they may come with important risks, especially for the heart.
The researchers compared these older drugs with a newer group of medications called DPP-4 inhibitors. These newer drugs work in a different way and are generally considered to have fewer side effects.
The results showed that patients taking sulfonylureas had a 36 percent higher risk of serious heart-related problems. These problems included heart attacks, strokes, heart failure, and even amputations. The risk was even higher for patients using basal insulin, where the chance of these events was about twice as high.
These findings are important because Type 2 diabetes itself already increases the risk of heart disease. Adding medications that may further increase this risk is a serious concern.
To better understand the impact, the researchers looked at how these risks affect large groups of patients. They found that for every 37 people treated with basal insulin over two years, one person would likely experience a major heart problem. For sulfonylureas, the number was one in every 103 people.
The study included data from over 132,000 patients who started second-line diabetes treatment. This large number gives a clearer picture of what happens in real-life situations, not just in controlled experiments.
Earlier studies often compared one drug with a placebo, but this research compared different real treatments. This makes the findings more useful for everyday medical decisions.
The results suggest that doctors and patients may need to rethink how they choose second-line diabetes treatments. Newer medications such as GLP-1 receptor agonists, SGLT-2 inhibitors, and DPP-4 inhibitors appear to have lower risks for heart problems.
Examples of these newer drugs include liraglutide, empagliflozin, and sitagliptin. These medicines not only help control blood sugar but may also offer some protection for the heart.
However, one major challenge is cost. These newer drugs are often more expensive, which can make them harder for patients to access. Because of this, many people still use older, cheaper medications despite the potential risks.
The researchers believe that this situation needs to change. They suggest that healthcare systems should consider both the benefits and the long-term risks when choosing treatments. Reducing heart problems in people with diabetes should be a key goal.
This study highlights an important issue in modern medicine. It is not enough for a drug to work well in lowering blood sugar. It must also be safe over the long term, especially for patients who may take it for many years.
For patients, the key message is not to stop taking medication without medical advice. Instead, it is important to have open discussions with doctors about the best treatment options. Understanding both the benefits and risks can help patients make better decisions about their health.
As more research becomes available, treatment guidelines may continue to change. This study is a step toward safer and more effective care for people living with Type 2 diabetes.
If you care about diabetes, please read studies about bananas and diabetes, and honey could help control blood sugar.
For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes and plant-based protein foods may help reverse type 2 diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
